Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

NCT02989194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: VIS410 low dose
DRUG: VIS410 high dose
DRUG: Placebo

Sponsor

Visterra, Inc.

Collaborators

[object Object]